The Claim
In mouse hepatocytes, fructose suppresses ubiquitination of ChREBPα and extends its half-life from approximately 2 hours to 5 hours, indicating that fructose enhances ChREBPα stability by reducing its proteasomal degradation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mouse liver cells, fructose reduces the tagging of ChREBPα for destruction, resulting in the protein lasting longer before being broken down by the proteasome.
See the scientific wording
In mouse hepatocytes, fructose suppresses ubiquitination of ChREBPα and extends its half-life from approximately 2 hours to 5 hours, indicating that fructose enhances ChREBPα stability by reducing its proteasomal degradation.
Fructose causes a protein called DDB1 to increase in liver cells, which marks another protein called CRY1 for destruction. When CRY1 is gone, it can no longer attach to ChREBPα and signal for its breakdown. Without this signal, ChREBPα avoids being tagged with ubiquitin and escapes destruction by the cell's protein-recycling system, so it builds up and stays active longer to turn on fat-making genes.
What the research says
1 studyStudy: DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1
Fructose makes a liver protein called ChREBPα last longer by stopping the cell from breaking it down, and this study shows exactly how that happens—fructose tricks a protein called DDB1 into protecting ChREBPα.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.